Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 52.0B | 64.8B | 53.6B | 51.2B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | 149.2M | — | — |
| Other operating expenses | 696.6M | 942.8M | 2.0B | 851.8M |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 56.7B | 54.9B | 51.8B | 51.0B |
| Tax provision | 12.0B | 11.8B | 11.0B | 10.6B |
| Net income | 44.7B | 43.1B | 40.8B | 40.4B |
| Basic EPS | 17.0 | — | 15.5 | 15.3 |
| Diluted EPS | 17.0 | — | 15.5 | 15.3 |
| Basic average shares | 2.6B | — | 2.6B | 2.6B |
| Diluted average shares | 2.6B | — | 2.6B | 2.6B |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | 54.9B | 51.8B | 51.0B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |